Vioxx Sparks Debate over Malpractice Reform

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/4181355/4181356" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Following the recent removal of the drug Vioxx from the market, lawmakers are reconsidering a portion of medical malpractice reform. Caps in the malpractice bill would affect pharmaceutical and medical product manufacturers. Democrats oppose the caps, but Sen. Orrin Hatch (R-UT) calls the situation a "feeding frenzy" for trial lawyers. NPR's Julie Rovner reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.